Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score -1.02
- Piotroski Score 4.00
- Grade Buy
- Symbol (ACET)
- Company Adicet Bio, Inc.
- Price $1.31
- Changes Percentage (3.57%)
- Change $0.05
- Day Low $1.26
- Day High $1.39
- Year High $3.77
Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune response, and enhance persistence for durable activity in patients. Its lead product in pipeline includes ADI-001, which is in Phase I clinical study for the treatment of non-Hodgkin's lymphoma. The company also engages in the development of ADI-002, which is undergoing preclinical studies for the treatment of various solid tumors. Adicet Bio, Inc. is based in Boston, Massachusetts.
- Last Earnings 09/06/2018
- Ex-Dividend for 5/16 Dividend 09/21/2018
- Dividend Payable 10/09/2018
- Today N/A
- Next Earnings (Estimated) 11/05/2024
- Fiscal Year End N/A
- Average Stock Price Target $32.50
- High Stock Price Target $38.00
- Low Stock Price Target $27.00
- Potential Upside/Downside N/A
- Consensus Rating Neutral
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$2.94
- Trailing P/E Ratio -0.46
- Forward P/E Ratio -0.46
- P/E Growth -0.46
- Net Income $-142,658,000
Income Statement
Quarterly
Annual
Latest News of ACET
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Facet Expects to Turn a Profit in a Year. Is an IPO Next?
Facet recently completed a $35 million capital raise, with hopes that it will be their final one before becoming profitable. Founded in 2016, Facet aims to revolutionize the investment advisory indust...
By MarketWatch | 3 weeks ago -
Mercer dominates in all facets, defeats Princeton 34-7
Mercer defeated Princeton 34-7 with key plays by Smith and Moore. Mercer dominated with a 376-196 total yardage advantage. Newbauer and Horne led the Bears to victory, while Princeton's Hipa struggled...
By AP NEWS | 3 weeks ago -
AI Scientists Win Nobel Prize, Meta's 'Movie Gen,' Spacetop Canceled
Geoff Hinton and John Hopfield won the 2024 Nobel Prize in Physics for their AI contributions. Meta unveils AI video generator "Movie Gen," while Sightful cancels Spacetop AR laptop for AR glasses sof...
By Forbes | 3 weeks ago